Novel tools for production and purification of recombinant adenoassociated virus vectors

Human Gene Therapy

Volumn 9, Issue 18, 1998, Pages 2745-2760

  Grimm, Dirk ^a   Kern, Andrea ^a   Rittner, Karola ^b   Kleinschmidt, Jürgen A ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b TRANSGENE S A   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; DNA PACKAGING; GENE THERAPY; HELPER VIRUS; IMMUNOFLUORESCENCE; NONHUMAN; PLASMID; VIRUS CAPSID; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS TITRATION;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ADENOVIRIDAE; DNA VIRUSES; MIRIDAE; MOUSE MAMMARY TUMOR VIRUS;

EID: 0032506752     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.18-2745     Document Type: Article

References (60)

1. ALEXANDER, I.E., RUSSELL, D.W., SPENCE, A.M., and MILLER, A.D. (1996). Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7, 841-850.
2. ALLEN, J.M., DEBELAK, D.J., REYNOLDS, T.C., and MILLER, A.D. (1997). Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination curing AAV vector production. J. Virol. 71, 6816-6822.
3. BALAGUE, C., KALLA, M., and ZHANG, W.W. (1997). Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71, 3299-3306.
4. BERNS, K.I., and BOHENSKY, R.A. (1987). Adeno-associated viruses: An update. Adv. Virus Res. 32, 243-305.
5. CHARTIER, C., DEGRYSE, E., GANTZER, M., DIETERLE, A., PAVIRANI, A., and MEHTALI, M. (1996). Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70, 4805-4810.
6. CHEN, C., and OKAYAMA, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
7. CHEUNG, A.K., HOGGAN, M.D., HAUSWIRTH, W.W., and BERNS, K.I. (1980). Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Virol. 54, 739-748.
8. CHIORINI, J.A., WENDTNER, C.M., URCELAY, E., SAFER, B., HALLEK, M., and KOTIN, R.M. (1995). High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene Ther. 6, 1531-1541.
9. CLARK, K.R., VOULGAROPOULOU, F., FRALEY, D.M., and JOHNSON, P.R. (1995). Cell lines fro the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341.
10. CONRAD, C.K., ALLEN, S.S., AFIONE, S.A., REYNOLDS, T.C., BECK, S.E., FEE MAKI, M., BARRAZZA ORTIZ, X., ADAMS, R., ASKIN, F.B., CARTER, B.J., GUGGINO, W.B., and FLOTTE, T.R. (1996). Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther. 8, 658-668.
11. CONWAY, J.E., ZOLOTUKHIN, S., MUZYCZKA, N., HAYWARD, G.S., and BYRNE, B.J. (1997). Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J. Virol. 71, 8780-8789.
12. DONG, J.Y., FAN, P.D., and FRIZZELL, R.A. (1996). Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7, 2101-2112.
13. FAN, P.D., and DONG, J.Y. (1997). Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV. Hum. Gene Ther. 8, 87-98.
14. FERRARI, F.K., SAMULSKI, T., SHENK T., and SAMULSKI, R.J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
15. FERRARI, F.K., XIAO, X., McCARTY, D., and SAMULSKI, R.J. (1997). New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors. Nature Med. 11, 1295-1297.
16. FISHER, K.J., GAO, G., WEITZMAN, M.D., DEMATTEO, R., BURDA, J., and WILSON, J.M. (1996a). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532.
17. FISHER, K.J., KELLEY, W.M., BURDA, J.F., and WILSON, J.M. (1996b). A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Hum. Gene Ther. 7, 2079-2087.
18. FISHER, K.H., JOOSS, K., ALSTON, J., YANG, Y., HAECKER, S.E., HIGH, K., PATHAK, R., RAPER, S.E., and WILSON, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med. 3, 306-312.
19. FLOTTE, T.R., AFIONE, S.A., and ZEITLIN, P.L. (1994). Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell. Mol. Biol. 5, 517-521.
20. FLOTTE, T.R., BARRAZA-ORTIZ, X., SOLOW, R., AFIONE, S.A., CARTER, B.J., and GUGGIONO, W.B. (1995). An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther. 1, 29-37.
21. HALBERT, C.L., STANDAERT, T.A., AITKEN, M.L., ALEXANDER, I.E., RUSSELL, D.W., and MILLER, A.D. (1997). Transduction by adeno-associated virus vectors in the rabbit airway: Efficiency, persistence, and readministration. J. Virol. 71, 5932-5941.
22. HEILBRONN, R., BURKLE, A., STEPHAN, S., and ZUR HAUSEN, H. (1990). The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J. Virol. 64, 3012-3018.
23. HERZOG, R.W., HAGSTROM, J.N., KUNG, S.H., TAI, S.J., WILSON, J.M., FISHER, K.J., and HIGH, K.A. (1997). Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 11, 5804-5809.
24. HIRT, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 2, 365-369.
25. JOHNSTON, K.M., JACOBY, D., PECHAN, P.A., FRAEFEL, C., BORGHESANI, P., SCHUBACK, D., DUNN, R.J., SMITH, F.I., and BREAKEFIELD, X.O. (1997). HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8, 359-370.
26. KAPLITT, M.G., LEONE, P., SAMULSKI, R.J., XIAO, X., PFAFF, D.W., O'MALLEY, K.L., and DURING, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 2, 148-154.
27. KEARNS, W.G., AFIONE, S.A., FULMER, S.B., PANG, M.C., ERIKSON, D., EGAN, M., LANDRUM, M.J., FLOTTE, T.R., and CUTTING, G.R. (1996). Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 9, 748-755.
28. KESSLER, P.D., PODSAKOFF, G.M., CHEN, X., McQUISTON, S.A., COLOSI, P.C., MATELIS, L.A., KURTZMAN, G.J., and BYRNE, B.J. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. U.S.A. 24, 14082-14087.
29. KOTIN, R.M., SINISCALCO, M., SAMULSKI, R.J., ZHU, X.D., HUNTER, L., LAUGHLIN, C.A., McLAUGHLIN, S., MUZYCZKA, N., ROCCHI, M., and BERNS, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 6, 2211-2215.
30. LAUGHLIN, C.A., CARDELLICHIO, C.B., and COON, H.C. (1986). Latent infection of KB cells with adeno-associated virus type 2. J. Virol. 60, 515-524.
31. LI, I., SAMULSKI, R.J., and XIAO, X. (1997). Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71, 5236-5243.
32. MALIK, P., McQUISTON, S.A., YU, X.J., PEPPER, K.A., KRALL, W.J., PODSAKOFF, G.M., KURTZMAN, G.J., and KOHN, D.B. (1997). Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J. Virol. 71, 1776-1783.
33. MAMOUNAS, M., LEAVITT, M., YU, M., and WONG-STAAL, F. (1995). Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes. Gene Ther. 6, 429-432.
34. McCOWN, T.J., XIAO, X., LI, J., BREESE, G.R., and SAMULSKI, R.J. (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713, 99-107.
35. MYERS, M.W., LAUGHLIN, C.A., JAY, F.T., and CARTER, B.J. (1980). Adenovirus helper function for growth of adeno-associated virus: Effect of temperature-sensitive mutations in adenovirus early gene region 2. J. Virol. 54, 65-75.
36. PODSAKOFF, G., WONG, K.K., JR., and CHATTERJEE, S. (1994). Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 68, 5656-5666.
37. PONNAZHAGAN, S., ERIKSON, D., KEARNS, W.G., ZHOU, S.Z., NAHREINI, P., WANG, X.S., and SRIVASTAVA, A. (1997). Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8, 275-284.
38. QUING, K., KHUNTIRAT, B., MAH, C., KUBE, D.M., WANG, X.S., PONNAZHAGAN, S., ZHOU, S., DWARKI, V.J., YODER, M.D., and SRIVASTAVA, A. (1998). Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol. 72, 1593-1599.
39. RUFFING, M., ZENTGRAF, H., and KLEINSCHMIDT, J.A. (1992). Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J. Virol. 66, 6922-6930.
40. RUSSELL, D.W., MILLER, A.W., and ALEXANDER, I.E. (1994). Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. U.S.A. 91, 8915-8919.
41. RUSSELL, D.W., ALEXANDER, I.E., and MILLER, A.D. (1995). DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 12, 5719-5723.
42. SALVETTI, A., ORÈVE, S., CHADEUF, G., FAVRE, D., CHEREL, Y., CHAMPION-ARNAUD, P., DAVID-AMELINE, J., and MOULLIER, P. (1998). Factors influencing recombinant adeno-associated virus production. Hum. Gene Ther. 9, 695-706.
43. SAMULSKI, R.J., CHANG, L.S., and SHENK, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63, 3822-3828.
44. SAMULSKI, R.J., ZHU, X., XIAO, X., BROOK, J.D., HOUSMAN, D.E., EPSTEIN, N., and HUNTER, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 12, 3941-3950. [Published erratum appears in EMBO J. 1992;11(3):1228].
45. SNYDER, R.O., XIAO, X., and SAMULSKI, R.J. (1996). Production of recombinant adeno-associated viral vectors. In Current Protocols in Human Genetics. N. Dracopoli, J. Haines, B. Krof, D. Moir, C. Morton, C. Seidman, J. Seidman, and D. Smith, eds. (John Wiley & Sons, New York) pp. 12.1.1-24.
46. SNYDER, R.O., SPRATT, S.K., LAGARDE, C., BOHL, D., KASPAR, B., SLOAN, B., COHEN, L.K., and DANOS, O. (1997). Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8, 1891-1900.
47. STRATFORD-PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M., and BRIAND, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 2, 626-630.
48. SUROSKY, R.T., URABE, M., GODWIN, S.G., McQUISTON, S.A., KURTZMAN, G.J., OZAWA, K., and NATSOULIS, G. (1997). Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 71, 7951-7959.
49. TAMAYOSE, K., HIRAI, Y., and SHIMADA, T. (1996). A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum. Gene Ther. 7, 507-513.
50. THIMMAPPAYA, B., WEINBERGER, C., SCHNEIDER, R.J., and SHENK, T. (1982). Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 2, 543-551.
51. THRASHER, A.J., DE ALWIS, M., CASIMIR, C.M., KINNON, C., PAGE, K., LEBROWSKI, J., SEGAL, A.W., and LEVINSKY, R.J. (1995). Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidase. Gene Ther. 7, 481-485.
52. VINCENT, K.A., PIRAINO, S.T., and WADSWORTH, S.C. (1997). Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J. Virol. 71, 1897-1905.
53. WALSH, C.E., LUI, J.M., XIAO, X., YOUNG, N.S., NIENHUIS, A.W., and SAMULSKI, R.J. (1992). Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. U.S.A. 15, 7257-7261.
54. WEGER, S., WISTUBA, A., GRIMM, D., and KLEINSCHMIDT, J.A. (1997). Control of adeno-associated virus type 2 cap gene expression: Relative influence of helper virus, terminal repeats, and Rep proteins. J. Virol. 71, 8437-8447.
55. WEITZMAN, M.D., FISHER, K.J., and WILSON, J.M. (1996). Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J. Virol. 70, 1845-1854.
56. WISTUBA, A., WEGER, S., KERN, A., and KLEINSCHMIDT, J.A. (1995). Intermediates of adeno-associated virus type 2 assembly: Identification of soluble complexes containing Rep and Cap proteins. J. Virol. 69, 5311-5319.
57. WISTUBA, A., KERN, A., WEGER, S., GRIMM, D., and KLEINSCHMIDT, J.A. (1997). Subcellular compartmentalization of adeno-associated virus type 2 assembly. J. Virol. 71, 1341-1352.
58. XIAO, X., LI, J., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adenoassociated virus vector. J. Virol. 70, 8098-8108.
59. XIAO, X., LI, J., and SAMULSKI, R.J. (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232.
60. ZOLOTUKHIN, S., POTTER, M., HAUSWIRTH, W.W., GUY, J., and MUZYCZKA, N. (1996). A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70, 4646-4654.